Sara Green joins Ten Bridge from Pfizer’s Centers for Therapeutic Innovation (CTI), where she spent five years leading communications for the start-up research unit. She helped build CTI from the ground up, creating the branding and messaging for this high-profile group within Pfizer, as well as launching its website. In addition, Sara’s remit included growing a collaborative, patient-focused culture, drawing on relationships she forged with disease foundations. Prior to CTI, Sara led U.S. communications for the Global Fund to Fight AIDS, Tuberculosis and Malaria—the world’s largest global health funder. Sara has also held communications roles at WGBH-Boston and BroadReach Healthcare. She holds a master’s degree from the Harvard School of Public Health and a bachelor’s degree from Duke University.
Tom Donovan brings to Ten Bridge experience from multiple assignments in London, Australia and New Zealand. His most recent role was as director of communications for Nexvet Biopharma, a NASDAQ-listed biotechnology company that was acquired by Zoetis in 2017. Leading to acquisition, Tom worked with the company's executive team across all aspects of corporate and investor communications, from its early funding rounds, re-incorporation in Ireland, global operational expansion and IPO. Prior to this, Tom worked in a variety of communications consultant or policy roles to private biotech companies and government innovation teams in Australia, including development of the Global Health Melbourne Plan. Prior to this, Tom worked in investor and public relations consultancy roles with ASX-listed biotechnology companies, and as a junior business journalist in New Zealand. Tom has a bachelor's degree in biomedical science and a master's degree (1st class honors) in bioscience enterprise, both from the University of Auckland.